carcinogen.In a recall notice posted on Saturday, Health Canada said some lots of the company’s prescription metformin drug APO-METFORMIN ER (extended release) 500-milligram tablets were being recalled.Metformin is a prescription drug used to control high blood sugar in patients with type 2 diabetes.
Health Canada said tests conducted by Apotex Inc. found one lot of its drugs contained N-nitrosodimethylamine (NDMA) “above the interim acceptable concentration limit.”“As a precautionary measure, the company is also recalling eight other lots because levels of NDMA in those products may increase over time,” the recall notice reads.Apotex Inc.